National Academies Press: OpenBook
« Previous: 7 A Path Toward Inclusion
Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2023. Inclusion of Pregnant and Lactating Persons in Clinical Trials: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26790.
×

A

References

Abduljalil, K., A. Pansari, and M. Jamei. 2020. Prediction of maternal pharmacokinetics using physiologically based pharmacokinetic models: Assessing the impact of the longitudinal changes in the activity of CYP1A2, CYP2D6 and CYP3A4 enzymes during pregnancy. Journal of Pharmacokinetics and Pharmacodynamics 47(4):361-383.

Adam, M. P., J. E. Polifka, and J. M. Friedman. 2011. Evolving knowledge of the teratogenicity of medications in human pregnancy. American Journal of Medical Genetics Part C: Seminars in Medical Genetics 157(3):175-182.

Baird, D. D., D. B. Dunson, M. C. Hill, D. Cousins, and J. M. Schectman. 2003. High cumulative incidence of uterine leiomyoma in Black and White women: Ultrasound evidence. American Journal of Obstetrics and Gynecology 188(1):100-107.

Bianchi, D. W., L. Kaeser, and A. N. Cernich. 2021. Involving pregnant individuals in clinical research on COVID-19 vaccines. JAMA 325(11):1041-1042.

Blehar, M. C., C. Spong, C. Grady, S. F. Goldkind, L. Sahin, and J. A. Clayton. 2013. Enrolling pregnant women: Issues in clinical research. Women’s Health Issues 23(1):e39-e45.

CDC (Centers for Disease Control and Prevention). 2019. Birth defects are common, costly, and critical. https://www.cdc.gov/ncbddd/birthdefects/infographic.html (accessed September 16, 2022).

CDC. 2022. COVID-19 vaccines while pregnant or breastfeeding. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html (accessed September 22, 2022).

DeSisto, C. L., B. Wallace, R. M. Simeone, K. Polen, J. Y. Ko, D. Meaney-Delman, and S. R. Ellington. 2021. Risk for stillbirth among women with and without COVID-19 at delivery hospitalization—United States, March 2020–September 2021. MMWR Morbidity and Mortality Weekly Report 70(47):1640-1645.

Edlow, A. G., V. M. Castro, L. L. Shook, A. J. Kaimal, and R. H. Perlis. 2022. Neurodevelop-mental outcomes at 1 year in infants of mothers who tested positive for SARS-CoV-2 during pregnancy. JAMA Network Open 5(6):e2215787.

FDA (U.S. Food and Drug Administration). 2018. Milestones in U.S. food and drug law. https://www.fda.gov/about-fda/fda-history/milestones-us-food-and-drug-law (accessed September 22, 2022).

Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2023. Inclusion of Pregnant and Lactating Persons in Clinical Trials: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26790.
×

FDA. 2020. Vaccines and related biological products advisory committee December 17, 2020 meeting presentation—FDA review of efficacy and safety of Moderna COVID-19 vaccine emergency use authorization request. https://www.fda.gov/media/144585/download (accessed September 22, 2022).

Hebert, M. F., T. R. Easterling, B. Kirby, D. B. Carr, M. L. Buchanan, T. Rutherford, K. E. Thummel, D. P. Fishbein, and J. D. Unadkat. 2008. Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: A University of Washington specialized center of research study. Clinical Pharmacology and Therapeutics 84(2):248-253.

HHS (U.S. Department of Health and Human Services). 2017. Charter—Task Force on Research Specific to Pregnant Women and Lactating Women. https://www.nichd.nih.gov/sites/default/files/2017-09/PRGLAC_Signed_Charter_201704.pdf (accessed October 10, 2022).

IOM (Institute of Medicine). 1994. Women and health research: Ethical and legal issues of including women in clinical studies, Volume 1. Washington, DC: The National Academies Press.

IOM. 2008. Addressing the barriers to pediatric drug development: Workshop summary. Edited by C. Vanchieri, A. S. Butler and A. Knutsen. Washington, DC: The National Academies Press.

IOM. 2010. Women’s health research: Progress, pitfalls, and promise. Washington, DC: The National Academies Press.

Kendig, S., J. P. Keats, M. C. Hoffman, L. B. Kay, E. S. Miller, T. A. Moore Simas, A. Frieder, B. Hackley, P. Indman, C. Raines, K. Semenuk, K. L. Wisner, and L. A. Lemieux. 2017. Consensus bundle on maternal mental health: Perinatal depression and anxiety. Obstetrics and Gynecology 129(3):422-430.

Krubiner, C. B., R. R. Faden, R. J. Cadigan, S. Z. Gilbert, L. M. Henry, M. O. Little, A. C. Mastroianni, E. E. Namey, K. A. Sullivan, and A. D. Lyerly. 2016. Advancing HIV research with pregnant women: Navigating challenges and opportunities. AIDS 30(15):2261-2265.

Krubiner, C. B., R. R. Faden, R. A. Karron, M. O. Little, A. D. Lyerly, J. S. Abramson, R. H. Beigi, A. R. Cravioto, A. P. Durbin, B. G. Gellin, S. B. Gupta, D. C. Kaslow, S. Kochhar, F. Luna, C. Saenz, J. S. Sheffield, P. O. Tindana, and PREVENT Working Group. 2021. Pregnant women and vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response. Vaccine 39(1):85-120.

Levine, R. J. 1995. Children as research subjects: Ethical and legal considerations. Child and Adolescent Psychiatric Clinics 4(4):853-868.

Mandavilli, A. 2020. What pregnant women should know about coronavirus. New York Times, April 2.

March of Dimes. 2020. Nowhere to go: Maternity care deserts across the U.S. (2020 report). https://www.marchofdimes.org/materials/2020-Maternity-Care-Report.pdf (accessed September 22, 2022).

Mastroianni, A. C., L. M. Henry, D. Robinson, T. Bailey, R. R. Faden, M. O. Little, and A. D. Lyerly. 2017. Research with pregnant women: New insights on legal decision-making. Hastings Center Report 47(3):38-45.

Mastroianni, A. C., R. Franceschini, S. L. Wicks, and L. M. Henry. 2020. The pathway forward: Insights on factors that facilitate research with pregnant women. Ethics Human Research 42(4):2-16. Erratum in: Ethics Human Research 2020. 42(5):16.

NASEM (National Academies of Sciences, Engineering, and Medicine). 2022. Improving representation in clinical trials and research: Building research equity for women and underrepresented groups. Washington, DC: The National Academies Press.

NICHD (National Institute of Child Health and Human Development). n.d. BPCA Best Pharmaceuticals for Children Act history. https://www.nichd.nih.gov/research/supported/bpca/history# (accessed October 10, 2022).

Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2023. Inclusion of Pregnant and Lactating Persons in Clinical Trials: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26790.
×

Prasad, S., E. Kalafat, H. Blakeway, R. Townsend, P. O’Brien, T. Morris E, Draycott, S. Thangaratinam, K. Le Doare, S. Ladhani, P. von Dadelszen, L. A. Magee, P. Heath, and A. Khalil. 2022. Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy. Nature Communications 13(1):2414.

Pew Research Center. 2021. Mobile fact sheet. https://www.pewresearch.org/internet/fact-sheet/mobile (accessed September 23, 2022).

Sparks, G., L. Lopes, A. Montero, L. Hamel, and M. Brodie. 2022. KFF Covid-19 vaccine monitor: Pregnancy misinformation—May 2022. https://www.kff.org/coronavirus-covid-19/poll-finding/kff-covid-19-vaccine-monitor-pregnancy-misinformation-may-2022 (accessed September 22, 2022).

Thurin, N. H., R. Pajouheshnia, G. Roberto, C. Dodd, G. Hyeraci, C. Bartolini, O. Paoletti, H. Nordeng, H. Wallach-Kildemoes, V. Ehrenstein, E. Dudukina, T. MacDonald, G. De Paoli, M. Loane, C. Damase-Michel, A. B. Beau, C. Droz-Perroteau, R. Lassalle, J. Bergman, K. Swart, T. Schink, C. Cavero-Carbonell, L. Barrachina-Bonet, A. GomezLumbreras, M. Giner-Soriano, M. Aragón, A. J. Neville, A. Puccini, A. Pierini, V. Ientile, A. Trifirò, A. Rissmann, M. K. Leinonen, V. Martikainen, S. Jordan, D. Thayer, I. Scanlon, M. E. Georgiou, M. Cunnington, M. Swertz, M. Sturkenboom, and R. Gini. 2022. From inception to ConcePTION: Genesis of a network to support better monitoring and communication of medication safety during pregnancy and breastfeeding. Clinical Pharmacology and Therapeutics 111(1):321-331.

van der Zande, I. S. E., R. van der Graaf, L. Hooft, and J. J. M. van Delden. 2018. Facilitators and barriers to pregnant women’s participation in research: A systematic review. Women and Birth 31(5):350-361.

Whitehead, C. L., and S. P. Walker. 2020. Consider pregnancy in COVID-19 therapeutic drug and vaccine trials. Lancet 395(10237):e92.

Wisner, K. L., D. K. Sit, M. C. McShea, D. M. Rizzo, R. A. Zoretich, C. L. Hughes, H. F. Eng, J. F. Luther, S. R. Wisniewski, M. L. Costantino, A. L. Confer, E. L. Moses-Kolko, C. S. Famy, and B. H. Hanusa. 2013. Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings. JAMA Psychiatry 70(5):490-498.

Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2023. Inclusion of Pregnant and Lactating Persons in Clinical Trials: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26790.
×

This page intentionally left blank.

Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2023. Inclusion of Pregnant and Lactating Persons in Clinical Trials: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26790.
×
Page 89
Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2023. Inclusion of Pregnant and Lactating Persons in Clinical Trials: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26790.
×
Page 90
Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2023. Inclusion of Pregnant and Lactating Persons in Clinical Trials: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26790.
×
Page 91
Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2023. Inclusion of Pregnant and Lactating Persons in Clinical Trials: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26790.
×
Page 92
Next: Appendix B: Workshop Agenda »
Inclusion of Pregnant and Lactating Persons in Clinical Trials: Proceedings of a Workshop Get This Book
×
 Inclusion of Pregnant and Lactating Persons in Clinical Trials: Proceedings of a Workshop
Buy Paperback | $23.00 Buy Ebook | $18.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Approximately 4 million pregnant people in the United States give birth annually, and 70 percent of these individuals take at least one prescription medication during their pregnancy. Yet, due to a number of historical, ethical, legal, scientific, and societal issues, pregnant and lactating persons are often excluded from clinical trials. As a result, pregnant and lactating persons are often taking drugs based on limited information about the benefits and risks to themselves and their developing or newborn baby.

The National Academies Forum on Drug Discovery, Development, and Translation convened a workshop in June 2022 for stakeholders to examine the current state of evidence generation for drug products used by pregnant and lactating persons and discuss barriers and opportunities for including these populations in clinical trials. This publication summarizes the presentations and discussion of the workshop.

READ FREE ONLINE

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!